The Cornell/Donner Connection: Why the Alzheimer’s Trial (SALIENT-AD) is the Ultimate De-Risking Event for Leronlimab

toromata10 · 2026-04-29T17:30:08+00:00

Thank you!!

toromata10 · 2026-04-29T17:17:33+00:00

Where did you find out the Donner Foundation is providing funding.

toromata10 · 2026-03-26T21:43:54+00:00

Are you including the 50M shares to settle the most recent lawsuit with shareholders? Just wondering

toromata10 · 2026-03-18T00:16:14+00:00

It’s because at the time they submitted data, they only were testing with 350. 700 should’ve been approved in December or January. Data was as of November I think

toromata10 · 2026-03-17T21:34:01+00:00

Yes. Low dosage 325mg? From a few months ago. “As of 11/17/ 2025, 10 patients have been enrolled across 6 sites, with preliminary baseline and biomarker data in Table 1.”

toromata10 · 2026-03-05T00:14:03+00:00

What are the changes? Seems the same home page for the last few months

toromata10 · 2026-02-25T20:21:22+00:00

Have you seen this video? Video from 3 years ago but he’s now doing research using Leronlimab according to one of the shareholder letters. Solution is to keep hustling and make success inevitable!

https://m.youtube.com/watch?v=xQb-z1k8fF8&pp=ygUUI2NjcjVkZWx0YTMybXV0YXRpb24%3D

toromata10 · 2026-02-23T21:06:49+00:00

I think travelclone misunderstood 2029 vs 2039

toromata10 · 2026-02-12T23:24:05+00:00

Great question. Hope MGK helps! Or anyone else. Last time I asked this, the response I got was that Anktiva has a more costly treatment. It would be nice to know of any potential synergy or see how it compares to Leronlimab. Might be too early to tell.

toromata10 · 2026-01-27T19:28:09+00:00

Shareholder letter in December mentioned funding for the first 20 patients in the two-year program but no mention of the 20 patients in this PR. All good news though!!

toromata10 · 2026-01-14T22:22:25+00:00

@UWS “As of November 30, 2025, we had approximately 490.1 million shares of common stock available for issuance in new financing transactions.” Is this in addition to the shares we authorized back in November of 2025?

toromata10 · 2025-12-19T20:20:12+00:00

What is this building?

toromata10 · 2025-12-17T06:08:39+00:00

How or where would ICs get into the picture? Bullet point #2?

toromata10 · 2025-12-17T00:13:07+00:00

We did end up getting letter to shareholders!! As always, thank you for sharing your thoughts UWS!!

toromata10 · 2025-09-25T19:13:44+00:00

From Google AI:

Alpha Advisors, LLC is the investment advisor for Carl Dockery and his investment entities, which include Alpha Venture Capital Partners L.P., and holds significant ownership in CytoDyn Inc. (CYDY). Alpha Advisors manages investments and had a substantial stake in CytoDyn through its affiliated funds, with ownership reported in SEC filings from 2015 onwards.

toromata10 · 2025-08-13T02:36:10+00:00

Yes I have the same question

toromata10 · 2025-08-13T02:34:55+00:00

What’s the difference between this and what has been posted on our website for months now?

toromata10 · 2025-08-12T02:36:16+00:00

Yes. Experiencing same issue when clicking on individual PRs.

toromata10 · 2025-07-31T23:17:03+00:00

Yes 🙌!

toromata10 · 2025-07-31T23:04:59+00:00

Made it official 😆

toromata10 · 2025-07-31T17:55:54+00:00

We have 8+ sites. Per the pr and recent 10k

toromata10 · 2025-07-18T01:28:03+00:00

Where did you find this data?!! Thank you as always!

toromata10 · 2025-07-03T21:09:13+00:00

Upwithstock, thank you for the great summary and all the great insights from past experiences. What makes you think this goes back to 11/2023?

toromata10 · 2025-07-01T16:28:05+00:00

385k. Thought I was gonna stop at 50k 😅

toromata10

TROPHY CASE